ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Valbiotis SA

Valbiotis SA (ALVAL)

1.382
-0.004
( -0.29% )
Updated: 04:54:33

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
1.382
Bid
1.37
Ask
1.384
Volume
46,984
1.34 Day's Range 1.386
1.07 52 Week Range 5.30
Market Cap
Previous Close
1.386
Open
1.342
Last Trade
635
@
1.382
Last Trade Time
04:54:33
Financial Volume
-
VWAP
-
Average Volume (3m)
92,500
Shares Outstanding
15,794,596
Dividend Yield
-
PE Ratio
-2.96
Earnings Per Share (EPS)
-0.47
Revenue
6.81M
Net Profit
-7.37M

About Valbiotis SA

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Paris, Paris, Fra
Founded
-
Valbiotis SA is listed in the Pharmaceutical Preparations sector of the Euronext with ticker ALVAL. The last closing price for Valbiotis was 1.39 €. Over the last year, Valbiotis shares have traded in a share price range of 1.07 € to 5.30 €.

Valbiotis currently has 15,794,596 shares outstanding. The market capitalization of Valbiotis is 21.89 € million. Valbiotis has a price to earnings ratio (PE ratio) of -2.96.

ALVAL Latest News

Valbiotis meldet durchschlagenden Erfolg der internationalen multizentrischen Phase-II/III-Studie REVERSE-IT zu TOTUM•63: nachgewiesene Wirksamkeit bei Hauptrisikofaktor für Typ-2-Diabetes

Die Studie erreichte ihr Ziel beim primären Endpunkt, der Senkung des Nüchternblutzuckers – Risikofaktor für Typ-2-Diabetes, bei einer Tagesdosis von 5 g und drei Verabreichungen pro Tag mit...

Valbiotis Announces the Large Success of the REVERSE-IT International Multicentric Phase II/III Clinical Study on TOTUM•63: Proven Efficacy on the Main Risk Factor of Developing Type 2 Diabetes

The study achieved its objective on the primary endpoint, the reduction of fasting blood glucose, a risk factor for type 2 diabetes, at a 5g daily dose in 3 intakes per day, with a high...

Valbiotis – Combined Annual Shareholders General Meeting held on May 2, 2023

Regulatory News: Valbiotis (FR0013254851 – ALVAL, PEA / SME eligible), a commercially oriented Research and Development company, committed to scientific innovation for preventing and combating...

Valbiotis annonce la mise à disposition du Document d’Enregistrement Universel

Regulatory News: Valbiotis (FR0013254851 – ALVAL, éligible PEA / PME) (Paris:ALVAL), entreprise de Recherche et Développement à dimension commerciale, engagée dans l’innovation scientifique, pour...

Valbiotis annonce la tenue de son Assemblée générale mixte des actionnaires le 2 mai 2023

Regulatory News: Valbiotis (FR0013254851 – ALVAL, éligible PEA / PME) (Paris:ALVAL), entreprise de Recherche et Développement à dimension commerciale, engagée dans l’innovation scientifique, pour...

Valbiotis veröffentlicht seine Jahresergebnisse 2022 und gibt ein Update zu seiner strategischen Roadmap

Eine Barposition von mehr als 20 Millionen Euro zum Ende 2022, die dem Unternehmen finanzielle Visibilität bis zum Ende des ersten Halbjahres 2024 verschafft Ein entscheidendes Jahr an der...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.014-1.002865329511.3961.3981.334412551.36064914DE
40.1128.81889763781.271.521.2121111561.37046459DE
120.15212.35772357721.231.521.15925001.32934192DE
260.21818.72852233681.1641.91.08950261.4147613DE
52-3.278-70.34334763954.665.31.07854572.01000058DE
156-5.478-79.85422740526.867.51.07449663.17832411DE
260-0.778-36.01851851852.168.381.07351273.61764132DE

ALVAL - Frequently Asked Questions (FAQ)

What is the current Valbiotis share price?
The current share price of Valbiotis is 1.382 €
How many Valbiotis shares are in issue?
Valbiotis has 15,794,596 shares in issue
What is the market cap of Valbiotis?
The market capitalisation of Valbiotis is EUR 21.89M
What is the 1 year trading range for Valbiotis share price?
Valbiotis has traded in the range of 1.07 € to 5.30 € during the past year
What is the PE ratio of Valbiotis?
The price to earnings ratio of Valbiotis is -2.96
What is the cash to sales ratio of Valbiotis?
The cash to sales ratio of Valbiotis is 3.2
What is the reporting currency for Valbiotis?
Valbiotis reports financial results in EUR
What is the latest annual turnover for Valbiotis?
The latest annual turnover of Valbiotis is EUR 6.81M
What is the latest annual profit for Valbiotis?
The latest annual profit of Valbiotis is EUR -7.37M
What is the registered address of Valbiotis?
The registered address for Valbiotis is ZI DES QUATRE CHEVALIERS 12F RUE PAUL VATINE, PERIGNY, PARIS, PARIS, 17180
What is the Valbiotis website address?
The website address for Valbiotis is www.valbiotis.com
Which industry sector does Valbiotis operate in?
Valbiotis operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ALEMSEuropean Medical Solutions
6.70 €
(37,122.22%)
14
CFNCofina SGPS SA
14.35 €
(1,921.13%)
854
DMSBSDiagnostic Medical Systems
0.006 €
(200.00%)
51k
ALTROTronic s Microsystems
5.00 €
(48.81%)
8
SEQUASequana medical NV
4.10 €
(48.55%)
1.62M
EIFDSTour Eiffel DS
0.0122 €
(-71.76%)
44.86k
MLCOTCoretech 5
0.0075 €
(-40.00%)
459
MLCMIScemi
3.46 €
(-13.50%)
78
ALAVIAdvini
12.40 €
(-10.79%)
7.79k
ALSASStradim Espac Fin
5.00 €
(-10.71%)
134
ATOAtos SE
0.0027 €
(17.39%)
2.17B
NEOENNeoen SA
39.71 €
(0.43%)
81.3M
BCPBanco Comercial Portugues SA
0.4615 €
(2.33%)
50.39M
ALHPIHopium SA
0.005 €
(0.00%)
11.41M
PHARMPharming Group NV
0.931 €
(4.26%)
7.05M

Discussion

View Full Feed
Ranb2khz Ranb2khz 6 minutes ago
Still Waters (Psalm 23) – Leanna Crawford, Ben Fuller & David Leonard (Lyric Video)

[yt]RSF8vw8O7qI[/yt]

https://www.youtube.com/watch?v=RSF8vw8O7qI






Risk vs Reward Risk vs Reward 9 minutes ago
5.20 PM
KULR
Konaploinks Konaploinks 10 minutes ago
Doc Bingo! Thus the AFRL 54.5 million dollar contract. We have the patents!
From chat gpt
Quantum teleportation involves transferring the quantum state of a particle from one location to another without moving the particle itself. This process relies on quantum entanglement and cla
IONQ
Risk vs Reward Risk vs Reward 10 minutes ago
The gap(s) might've been filled intra day. As this has been quite volitle during the trading day. I think yesterday we dropped from 4.93 to 4.18 and Ruth back up to 4.88 ( as an example ) 

But hour are correct in instances like kulr is trading,  sometimes those gaps never fill 
KULR
sam1933 sam1933 10 minutes ago
I like how this fellow views the future of cryptocurrencies http://www.youtube.com/watch?v=iwXiLSh4IoU
HBARUSD
Swampy83 Swampy83 11 minutes ago
Is Prodigy still in business? Sorry, let me rephrase that question again:
Did Prodigy ever went to business? If so, how come there are absolutely no PRs of it, no numbers nothing telling us about its success?
Thank you
CNNA
extrinsic55 extrinsic55 13 minutes ago
KWE ask .72 ClimbContinues
KWE
Risk vs Reward Risk vs Reward 13 minutes ago
Much respect to you and the 10th Mountain Division Sir !! 
KULR
extrinsic55 extrinsic55 13 minutes ago
KWE ask .72 ClimbContinues
KWE
extrinsic55 extrinsic55 14 minutes ago
KWE ask .72 ClimbContinues
KWE
Wingsjr Wingsjr 15 minutes ago
That won’t ever change
as long as Cali stays blue. I’m in the same boat here in NY.
FNMA
evanstony evanstony 16 minutes ago
Kab, you are making a very good case for the "why do it"! Excellent read.
NWBO
Seminole Red Seminole Red 18 minutes ago
RIP, Fred Lorenzen: NASCAR Star Who Changed the Sport Forever

f you are at all a NASCAR fan, likely you’re aware that Hall of Fame driver Fred Lorenzen died last week. Possibly you read the statement issued by NASCAR Chairman and CEO Jim France: “Fred Lorenzen was one of NASCAR’s firs
gdog gdog 19 minutes ago
My$33.34 buy is looking good at $39.00 this a.m.
Number sleven Number sleven 20 minutes ago
RMB, The report is for global growth. North America 8.5%. Europe 8%, Asia 10%. Generic companies only have access to part of the North America market. Take a look at the key players section. I don't see Hikma listed. It would be nice to have access to the full report.
Sleven,
AMRN
gdog gdog 20 minutes ago
TEM my $33.00 buy is looking good here @ $39.00
john1311 john1311 20 minutes ago
Thanks, Hunch, hopes you have a peaceful and profitable new year...
OGI
infamous infamous 22 minutes ago
he definitely bought in the pennies. IMO All the bashers in OTCs are the ones who got burned and now are disgruntled
DBMM
Risk vs Reward Risk vs Reward 25 minutes ago
At what price do you believe the gaps exist ? 
KULR
Hi_Lo Hi_Lo 25 minutes ago
I warned everyone about this stock.

First clue was having a well known liar, manipulator and pump and dumper posting here.
CRTG
hopester hopester 28 minutes ago
Not really ! Giving account of ones investment history offers a clue on how easy is it to be "stupid". You own the Fisker blunder for not doing your research or understanding the importance of it. That should be noted in your appraisal of FCEL and the results from it.
FCEL
Konaploinks Konaploinks 30 minutes ago
Wow Doc. That’s a lot to digest. But yeah. I always knew v was way way ahead of its time. Electromagnetic Path or EmPath for starters. Teleportation of the data over existing fiber is huge! And yes the repeaters could be installed as I’ve read that the Chinese are already doing this. This is all com
Bull_Dolphin Bull_Dolphin 31 minutes ago
The Dogs of Christmas:

https://x.com/Pismo_B/status/1871980116903120959
Konaploinks Konaploinks 33 minutes ago
W